GlassScriptPhysician profile
Lauren Maher
NPI 1942643895
$940.73
in general payments reported to CMS, 2019-2025
16 companies · $14.18 in 2025
The $14.18 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $106 · 2021: $18.02 · 2022: $91.22 · 2023: $60.67 · 2024: $69.37 · 2025: $14.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $176.23 | 2019-2020 | |
| Allergan, INC. | $152.01 | 2019-2020 | |
| Hologic Sales and Service, LLC | $149.40 | 2019-2023 | Aptima |
| Vertical Pharmaceuticals, LLC | $139.21 | 2019 | |
| Therapeuticsmd, INC. | $57.81 | 2019-2020 | |
| Daiichi Sankyo INC. | $47.05 | 2019 | |
| Sumitomo Pharma America, INC. | $45.69 | 2024 | Gemtesa |
| Lupin INC. | $33.44 | 2019-2020 | |
| Astellas Pharma US INC | $23.68 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $20.66 | 2023 | |
| Coopersurgical, INC. | $20.14 | 2023 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $18.02 | 2021 | |
| Mylan Pharmaceuticals INC. | $17.67 | 2020 | |
| Millicent US INC | $14.18 | 2025 | Femring, Intrarosa |
| Exeltis, USA INC. | $13.54 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.